Cite
HARVARD Citation
Stam, M. et al. (2018). Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial). BMJ open. 8 (7), p. . [Online].